English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Article details
25 June 2020 - EPICO: EPIgenetic Therapy for the treatment of COronavirus

As part of the measures to support the development of collaborations for the identification of therapies and diagnostic, protection and analysis systems to combat the Coronavirus emergency and other viral emergencies of the future, the Lombardy Region has financed the project "EPIgenetic Therapy for the treatment of COronavirus infections "- Acronym: EPICO - presented by Italfarmaco SpA, the European Institute of Oncology, the  ItalianNational Institute of Health and the Experimental Zooprophylactic Institute of Lombardy and Emilia Romagna" Bruno Umbertini ". The project aims to create synergies between industry and centers of scientific excellence with the aim of identifying highly innovative treatments for the pathologies associated with SARS Cov-2 infection and will have total eligible costs of € 1,079,353.24.